Tech Company Financing Transactions
Biolevate Funding Round
Orange Ventures, RAISE Investissement and EQT Ventures joined a $34 million Series A capital raise for Biolevate. This VC investment round was announced on 9/22/2026.
Transaction Overview
Company Name
Announced On
9/22/2026
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series A
Investors
Orange Ventures (Lead Investor)
RAISE Investissement (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate international expansion, expand its presence into the United States with a new office in Boston, deepen product capabilities, and scale deployments with life sciences organisations.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Undisclosed
Paris, Undisclosed
France
Paris, Undisclosed
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Biolevate was founded in Paris in the blooming ecosystem of AI tech companies; Founded in 2023 by a team of visionaries passionate about the limitless potential of artificial intelligence, Biolevate was established to address a critical challenge: accelerating the development of new therapies to save lives. Our founders combined innovative AI tools to transform key phases of life science projects, significantly reducing the time to market for treatments while ensuring exceptional accuracy and efficiency.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Belafa
Browse more venture capital transactions:
Prev: 9/22/2026: Teal Health venture capital transaction
Next: 9/22/2026: Voxela venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs